RT Journal Article
SR Electronic
T1 Unveiling the crucial neuronal role of the proteasomal ATPase subunit gene <em>PSMC5</em> in neurodevelopmental proteasomopathies
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.01.13.24301174
DO 10.1101/2024.01.13.24301174
A1 Küry, Sébastien
A1 Stanton, Janelle E.
A1 van Woerden, Geeske
A1 Hsieh, Tzung-Chien
A1 Rosenfelt, Cory
A1 Scott-Boyer, Marie Pier
A1 Most, Victoria
A1 Wang, Tianyun
A1 Papendorf, Jonas Johannes
A1 de Konink, Charlotte
A1 Deb, Wallid
A1 Vignard, Virginie
A1 Studencka-Turski, Maja
A1 Besnard, Thomas
A1 Hajdukowicz, Anna Marta
A1 Thiel, Franziska
A1 Möller, Sophie
A1 Florenceau, Laëtitia
A1 Cuinat, Silvestre
A1 Marsac, Sylvain
A1 Wentzensen, Ingrid
A1 Tuttle, Annabelle
A1 Forster, Cara
A1 Striesow, Johanna
A1 Golnik, Richard
A1 Ortiz, Damara
A1 Jenkins, Laura
A1 Rosenfeld, Jill A.
A1 Ziegler, Alban
A1 Houdayer, Clara
A1 Bonneau, Dominique
A1 Torti, Erin
A1 Begtrup, Amber
A1 Monaghan, Kristin G.
A1 Mullegama, Sureni V.
A1 Volker-Touw, C.M.L. (Nienke)
A1 van Gassen, Koen L. I.
A1 Oegema, Renske
A1 de Pagter, Mirjam
A1 Steindl, Katharina
A1 Rauch, Anita
A1 Ivanovski, Ivan
A1 McDonald, Kimberly
A1 Boothe, Emily
A1 Dauber, Andrew
A1 Baker, Janice
A1 Fabie, Noelle Andrea V
A1 Bernier, Raphael A.
A1 Turner, Tychele N.
A1 Srivastava, Siddharth
A1 Dies, Kira A.
A1 Swanson, Lindsay
A1 Costin, Carrie
A1 Jobling, Rebekah K.
A1 Pappas, John
A1 Rabin, Rachel
A1 Niyazov, Dmitriy
A1 Tsai, Anne Chun-Hui
A1 Kovak, Karen
A1 Beck, David B.
A1 Malicdan, MCV
A1 Adams, David R.
A1 Wolfe, Lynne
A1 Ganetzky, Rebecca D.
A1 Muraresku, Colleen
A1 Babikyan, Davit
A1 Sedláček, Zdeněk
A1 Hančárová, Miroslava
A1 Timberlake, Andrew T.
A1 Al Saif, Hind
A1 Nestler, Berkley
A1 King, Kayla
A1 Hajianpour, MJ
A1 Costain, Gregory
A1 Prendergast, D’Arcy
A1 Li, Chumei
A1 Geneviève, David
A1 Vitobello, Antonio
A1 Sorlin, Arthur
A1 Philippe, Christophe
A1 Harel, Tamar
A1 Toker, Ori
A1 Sabir, Ataf
A1 Lim, Derek
A1 Hamilton, Mark
A1 Bryson, Lisa
A1 Cleary, Elaine
A1 Weber, Sacha
A1 Hoffman, Trevor L.
A1 Cueto-González, Anna Maria
A1 Tizzano, Eduardo Fidel
A1 Gómez-Andrés, David
A1 Codina-Solà, Marta
A1 Ververi, Athina
A1 Pavlidou, Efterpi
A1 Lambropoulos, Alexandros
A1 Garganis, Kyriakos
A1 Rio, Marlène
A1 Levy, Jonathan
A1 Jurgensmeyer, Sarah
A1 McRae, Anne M.
A1 Lessard, Mathieu Kent
A1 D’Agostino, Maria Daniela
A1 De Bie, Isabelle
A1 Wegler, Meret
A1 Jamra, Rami Abou
A1 Kamphausen, Susanne B.
A1 Bothe, Viktoria
A1 Busch, Larissa M.
A1 Völker, Uwe
A1 Hammer, Elke
A1 Wende, Kristian
A1 Cogné, Benjamin
A1 Isidor, Bertrand
A1 Meiler, Jens
A1 Bosc-Rosati, Amélie
A1 Marcoux, Julien
A1 Bousquet, Marie-Pierre
A1 Poschmann, Jeremie
A1 Laumonnier, Frédéric
A1 Hildebrand, Peter W.
A1 Eichler, Evan E.
A1 McWalter, Kirsty
A1 Krawitz, Peter M.
A1 Droit, Arnaud
A1 Elgersma, Ype
A1 Grabrucker, Andreas M.
A1 Bolduc, Francois V.
A1 Bézieau, Stéphane
A1 Ebstein, Frédéric
A1 Krüger, Elke
YR 2024
UL http://medrxiv.org/content/early/2024/01/26/2024.01.13.24301174.abstract
AB Neurodevelopmental proteasomopathies represent a distinctive category of neurodevelopmental disorders (NDD) characterized by genetic variations within the 26S proteasome, a protein complex governing eukaryotic cellular protein homeostasis. In our comprehensive study, we identified 23 unique variants in PSMC5, which encodes the AAA-ATPase proteasome subunit PSMC5/Rpt6, causing syndromic NDD in 38 unrelated individuals. Overexpression of PSMC5 variants altered human hippocampal neuron morphology, while PSMC5 knockdown led to impaired reversal learning in flies and loss of excitatory synapses in rat hippocampal neurons. PSMC5 loss-of-function resulted in abnormal protein aggregation, profoundly impacting innate immune signaling, mitophagy rates, and lipid metabolism in affected individuals. Importantly, targeting key components of the integrated stress response, such as PKR and GCN2 kinases, ameliorated immune dysregulations in cells from affected individuals. These findings significantly advance our understanding of the molecular mechanisms underlying neurodevelopmental proteasomopathies, provide links to research in neurodegenerative diseases, and open up potential therapeutic avenues.Competing Interest StatementThe Department of Molecular and Human Genetics at Baylor College of Medicine receives revenue from clinical genetic testing completed at Baylor Genetics Laboratory. EEE is a scientific advisory board (SAB) member of Variant Bio, Inc. AT and IW are employees of GeneDx, LLC.Funding StatementFor this work, SK awarded research grants from the Agence Nationale de la Recherche (ANR) for the project ANR-21-CE17-0005 (UPS-NDDecipher) and as a partner of the European Joint Programme on Rare Diseases (EJP RD) for the project ANR-22-RAR4-0001-01 (UPS-NDDiag), from la Region des Pays de la Loire as part of the National Trajectory program for the project TN_2021_AAP_UPS-NDDECIPHER_INSERM_154550, and from Nantes University Hospital (AOI 2021; grant RC22_0020) for the BioTND-UPS biobank. The EJP RD initiative has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement Number 825575. EK received funding from the German Research Foundation (RTG PRO 2719) and the work was further supported by COST (European Cooperation in Science and Technology) Action ProteoCure CA20113 for EK. The authors are grateful to Robert Beyer and Anne Brandenburg for their excellent technical assistance. FE is a recipient of an I-SITE NExT Junior Talent Chair. SB received financial support from the University Hospital Center (CHU) of Nantes for the BioTND-UPS biobank (PROG/09/72-03). The TND-UPS project led by SB, SK and FE is funded for 3 years through the patronage of the Mutuelles AXA as part of its health program dedicated to supporting innovative research projects in France. This research was supported, in part, by funding from the National Institutes of Health (NIH) grant R01MH101221 to EEE, who is an investigator of the Howard Hughes Medical Institute; from the National Natural Science Foundation of China (grant 82201314) and the Fundamental Research Funds for the Central Universities starting fund (grant BMU2022RCZX038) to T.W.; from the National Institutes of Health and the National Institute of Neurological Disorders and Stroke (NIH-NINDS grant K23NS119666) to S.S.; from the European Reference Networks (ERN) CRANIO and ITHACA to A.M.C-G.; from the ERN on Neurological Diseases ERN-RND to D.G-A.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of CHU de Nantes gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesMass spectrometry proteomics data are available via ProteomeXchange with identifier PXD048558. Lipidomics data have deposited in a repository through the Metabolomics Workbench; the identifier will be communicated once attributed.